Stopping Plaquenil (hydroxychloroquine) for lupus significantly increases your risk of a disease flare, even if your lupus has been quiet for months or years. A randomized controlled trial found that patients who stopped the drug were 2.5 times more likely to flare than those who continued it. Because hydroxychloroquine works slowly and stays in your body for a long time, you may not notice problems right away, but the consequences of stopping tend to show up within weeks to months.
Why Flares Don’t Happen Immediately
Hydroxychloroquine has an unusually long half-life of 40 to 50 days, meaning it takes that long for just half the drug to leave your system. Traces remain detectable in urine for at least three months after your last dose. This slow clearance acts as a buffer. You might feel fine for several weeks after stopping because the drug is still circulating, gradually declining. That lag can be misleading. It may convince you that stopping was harmless, right up until your immune system ramps back up and symptoms return.
How Much Flare Risk Increases
The numbers are fairly clear. In a large study comparing lupus patients who stopped hydroxychloroquine to those who stayed on it, flares occurred in 61.4% of those who stopped versus 45.1% of those who continued. That difference was statistically significant.
There’s one encouraging finding buried in the data: patients who tapered off gradually rather than stopping abruptly had noticeably fewer flares (45.9% compared to 72.6% among those who quit cold turkey). If you and your doctor decide discontinuation makes sense, a slow taper gives your body time to adjust and may cut your flare risk nearly in half compared to stopping all at once.
What a Flare Can Look Like
Lupus flares vary from person to person, but common symptoms after losing the protection of hydroxychloroquine include joint pain and swelling, fatigue, skin rashes (especially the butterfly rash across the cheeks), mouth sores, and increased sensitivity to sunlight. Some people experience more serious flares involving the kidneys, heart lining, or lungs. If your lupus was well controlled on Plaquenil, a flare after stopping can feel like a sharp reversal, particularly because you may have forgotten what uncontrolled disease activity feels like.
Effects Beyond Flare Control
Hydroxychloroquine does more than suppress immune overactivity. It also has measurable effects on your cardiovascular health. Studies show that three months of treatment lowers total cholesterol by about 7.6% and LDL (“bad”) cholesterol by roughly 13.7%. In one study, the rate of abnormal lipid levels among lupus patients dropped from 26% to 12.5% while on the drug. When you stop, those lipid-lowering benefits disappear, which matters because lupus itself already raises your risk of heart disease.
Long-term data from the LUMINA cohort, a large multiethnic study of lupus patients in the United States, found that hydroxychloroquine use was strongly associated with better survival. Patients taking the drug had roughly 70 to 87% lower odds of dying during the study period compared to matched patients who were not on it. That protective effect held up even after researchers adjusted for other factors that influence survival. Stopping the medication means losing that long-term survival advantage.
Stopping During Pregnancy
Some women consider stopping Plaquenil when they become pregnant, worried about exposing the baby to medication. Current evidence actually supports the opposite approach. Data from the Hopkins Lupus Cohort showed that women who stopped hydroxychloroquine for pregnancy had significantly higher rates of lupus flares, and flares during pregnancy carry their own risks to both mother and baby. A meta-analysis found that women taking hydroxychloroquine during pregnancy had lower odds of highly active lupus, and among those with low disease activity, the drug cut the odds of preterm delivery nearly in half.
Hydroxychloroquine did not appear to increase the risk of fetal loss or preeclampsia. For most women with lupus, staying on the medication during pregnancy is considered safer than stopping it.
When Stopping Is Medically Necessary
The main reason doctors recommend stopping hydroxychloroquine is retinal toxicity, a form of eye damage that can develop after years of use. The American Academy of Ophthalmology recommends keeping your daily dose at or below 5.0 mg per kilogram of body weight to minimize this risk. Doses near 6.0 mg/kg per day accelerate the danger substantially, and patients taking double the recommended amount can develop signs of toxicity within the first year or two.
Regular eye screenings can catch the earliest changes before vision is affected. If mild retinal changes are detected and the drug is stopped promptly, significant progression is unlikely. But if the damage has already reached deeper layers of the retina, it can continue to worsen even after you stop taking the medication, potentially leading to permanent central vision loss. This is why routine eye exams while on Plaquenil are so important: they give you and your doctor the chance to stop early enough that the eyes recover.
The decision to discontinue is always a collaboration between you, your rheumatologist, and your ophthalmologist, weighing the risk of retinal damage against the substantial benefits the drug provides for lupus control, cardiovascular health, and survival.
If You’re Thinking About Stopping
The most important thing the research shows is that abrupt, unsupervised discontinuation carries the highest risk. If side effects, cost, or personal preference are driving your decision, talk to your rheumatologist before making changes. A gradual taper under medical supervision can reduce your flare risk meaningfully compared to stopping on your own. Your doctor may also want to monitor you more closely in the months after discontinuation, since the drug’s long half-life means the window for a rebound flare extends well beyond your last pill.
If you’ve already stopped and haven’t flared, that doesn’t necessarily mean you’re in the clear. The protective effects wear off slowly over months, and the cumulative risks, especially to your heart and kidneys, build quietly over years. For most people with lupus, the evidence strongly favors staying on hydroxychloroquine for as long as it remains safe to do so.